Law Offices of Howard G. Smith Announces Investigation on Behalf of Shareholders of BioForm Medical, Inc.

Law Offices of Howard G. Smith announces that it is investigating potential claims against the board of directors of BioForm Medical, Inc. (“BioForm Medical” or the “Company”) (Nasdaq:BFRM) related to the Company’s merger agreement with Merz Pharma Group ("Merz") – a privately held company based in Frankfurt, Germany – to acquire BioForm Medical in a cash transaction valued at approximately $253 million, based on the Company’s outstanding shares of common stock.

Under the terms of a definitive agreement entered into by the parties, Merz will acquire all of the outstanding shares of BioForm Medical for $5.45 per share in cash pursuant to a cash tender offer followed by a second-step merger. Following completion of the transaction, BioForm Medical will become a wholly-owned subsidiary of Merz and will be renamed Merz Aesthetics. The investigation concerns possible breaches of fiduciary duty and other violations of law related to approval of the transaction by the BioForm Medical board of directors.

If you own shares of BioForm Medical, Inc., if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at [phone], Toll Free at [phone], or by email to [e-mail], or visit our website at http://www.howardsmithlaw.com.